Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02337205 · ClinicalTrials.gov registry record · Phase 1
Ph 1, Single-Center, Safety, Tolerability & Pharmacokinetic Study of KX2 391 Ointment in Subj. w Actinic Keratosis
A Phase 1 study of Actinic Keratosis, sponsored by Athenex.
- Completed
- Registry status
- Phase 1
- Development phase
- 29
- Enrollment target
- 1
- Study location
NCT02337205 is a Phase 1 study of Actinic Keratosis that has completed, run by Athenex. The registered enrollment target is 29 participants, below the 187-participant average among 16 other Actinic Keratosis trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02337205, a Phase 1 study of Actinic Keratosis, has completed, sponsored by Athenex.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a phase 1 study to access the safety and tolerability of KX2-391 ointment in subjects who have Actinic Keratosis. This study will also access the amount of KX2-391 drug that enters the blood stream through dermal application of the ointment.
Conditions Studied
Interventions
- DRUG KX2-391 Ointment
Study Locations (1)
Texas
- DermResearch, Inc. - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2014-12 |
| Est. Completion | 2016-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02337205
The ClinicalTrials.gov registry entry for NCT02337205 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 187-participant average among 16 other Actinic Keratosis trials with a reported enrollment target (84% lower). The listed sponsor is Athenex, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Actinic Keratosis appearing as the primary indexed condition, and to 1 intervention - of which KX2-391 Ointment is the first listed.
NCT02337205 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02337205 about?
NCT02337205 is a clinical study titled "Ph 1, Single-Center, Safety, Tolerability & Pharmacokinetic Study of KX2 391 Ointment in Subj. w Actinic Keratosis". This is a phase 1 study to access the safety and tolerability of KX2-391 ointment in subjects who have Actinic Keratosis. This study will also access the amount of KX2-391 drug that enters the blood stream through dermal application of the ointment.
What is the current status of trial NCT02337205?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 29 participants. The study started on 2014-12. Estimated completion is 2016-03.
What conditions does trial NCT02337205 study?
This clinical trial studies the following conditions: Actinic Keratosis.
What interventions are being tested in trial NCT02337205?
The interventions under investigation include: KX2-391 Ointment (DRUG).
Who is sponsoring clinical trial NCT02337205?
This trial is sponsored by Athenex, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02337205 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Actinic Keratosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy
RECRUITING · Phase 1
-
A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers
COMPLETED · Phase 1
-
PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects
COMPLETED · Phase 1
-
The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans
RECRUITING · Phase 2
-
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
ACTIVE NOT RECRUITING · Phase 3
-
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.